Jupiter Neurosciences Amends Bylaws to Set 1/3 Quorum

What Happened
Jupiter Neurosciences, Inc. filed an 8-K on Sept 3, 2026 reporting that its Board of Directors approved an amendment to the company’s Amended and Restated Bylaws on August 28, 2026. The Amendment changes the quorum requirement so that holders of one‑third (1/3) of the voting power, present in person or represented by proxy, shall constitute a quorum at a meeting of stockholders. The full text of the Amendment is filed as Exhibit 3.1 to the report.

Key Details

• Board approval date: August 28, 2026; effective upon Board adoption.
• New quorum: holders of one‑third (1/3) of the voting power present in person or by proxy.
• Full amendment text is included as Exhibit 3.1 in the 8‑K filing.
• Filing date of the Form 8‑K: September 3, 2026.

Why It Matters
This amendment changes the number of voting power required to conduct business at a stockholder meeting, which can affect how easily the company can achieve a valid quorum and proceed with votes. Investors may want to review the full amendment (Exhibit 3.1) for any related procedural changes and consider potential governance implications for shareholder meetings and vote outcomes.